السوق العالمية لعلاج داء الأنكلستوما - اتجاهات الصناعة والتوقعات حتى عام 2028

تحليل السوق والرؤى : سوق علاج داء الأنكلستوما العالمي

من المتوقع أن يحقق سوق علاج داء الأنكلستوما نموًا في السوق في الفترة المتوقعة 2021-2028. تحلل شركة Data Bridge Market Research السوق لتتوقع نموًا بمعدل نمو سنوي مركب قدره 4.20% في الفترة المتوقعة المذكورة أعلاه.

داء الأنكلستوما هو مرض طفيلي نادر يحدث بسبب ديدان الأنكلستوما. تنتقل يرقات هذه الديدان إلى جسم الإنسان عندما يتلامس الجلد المكسور في القدمين مع التربة الملوثة. تنتقل عبر مجرى الدم إلى الرئتين والأمعاء وتبدأ في التكاثر. يُطلق على داء الأنكلستوما أيضًا عدوى الدودة الشصية. تشمل أعراض هذه الحالة آلام البطن وفقر الدم والإسهال وعسر الهضم والنزيف المعوي وفرط الحمضات وسوء التغذية.

إن ارتفاع معدل انتشار داء الأنكلستوما، وتزايد الإنفاق على الرعاية الصحية ، والتقدم الطبي، وسوء النظافة، وتزايد التمويل الحكومي، والمبادرات المتزايدة من قبل الحكومة والمنظمات الخاصة لنشر الوعي حول هذا المرض النادر وتدابير الوقاية منه هي العوامل التي من شأنها توسيع سوق علاج داء الأنكلستوما.

ستوفر الزيادة في أنشطة البحث والتطوير وأسواق التجارب السريرية الجارية فرصًا مفيدة لسوق علاج داء الأنكلستوما في الفترة المتوقعة 2021-2028.

ومع ذلك، فإن التكلفة العالية للعلاج والآثار الجانبية المرتبطة بالأدوية هي العوامل التي ستعيق نمو السوق. إن الافتقار إلى الوعي فيما يتعلق بالتدابير الوقائية ضد داء الأنكلستوما سيشكل تحديًا لسوق علاج داء الأنكلستوما في الفترة المتوقعة المذكورة أعلاه.

This ancylostomiasis treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the ancylostomiasis treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Ancylostomiasis Treatment Market Scope and Market Size

The ancylostomiasis treatment market is segmented on the basis of treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of treatment, the ancylostomiasis treatment market is segmented into anthelminthic drugs, blood transfusion and others. Anthelminthic drugs are further sub-segmented into albendazole, mebendazole and pyrantel pamoate.
• On the basis of diagnosis, the ancylostomiasis treatment market is segmented into serologic tests, physical examination, ova and parasites stool test, microscopic examination and others.
• On the basis of dosage, the ancylostomiasis treatment market is segmented into tablet, injection and others.
• On the basis of route of administration, the ancylostomiasis treatment market is segmented into oral, intravenous and others.
• On the basis of symptoms, the ancylostomiasis treatment market is segmented into abdominal pain, anaemia, diarrhea, dyspepsia, intestinal bleeding, eosinophilia and others.
• On the basis of end-users, the ancylostomiasis treatment market is segmented into clinic, hospital and others.

The ancylostomiasis treatment market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Ancylostomiasis Treatment Market Country Level Analysis

Ancylostomiasis treatment market is analyzed and market size information is provided by the country, treatment, diagnosis, dosage, route of administration, symptoms, end-users and distribution channel as referenced above.

The countries covered in the ancylostomiasis treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the ancylostomiasis treatment market due to the presence of major key players, growing investment for R&D activities and well-developed healthcare sector in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, rising investment in the healthcare infrastructure and growing disposable income.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Ancylostomiasis treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Ancylostomiasis Treatment Market Share Analysis

Ancylostomiasis treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to ancylostomiasis treatment market research.

اللاعبون الرئيسيون الذين تم تغطيتهم في تقرير سوق علاج داء الأنكلستوما هم Cipla Inc. و Johnson & Johnson Private Limited و Mankind Pharma و Sun Pharmaceutical Industries Ltd. و Merck KGaA و Amneal Pharmaceuticals LLC. و Boehringer Ingelheim International GmbH. و Zoetis و Merck Sharp & Dohme Corp. و Pfizer Inc. و GlaxoSmithKline plc و Novartis AG و Bayer AG و SeQuent و Lasa Supergenerics Ltd. و KAMalle Pharmaceuticals و LEO BIO-CARE PVT. LTD. و Salius Pharma Private Limited. و Fredun Group و Hubei Zhongjia-Chem Pharmaceutical Co.، Ltd. و Ashish Life Science و AdvaCare Pharma، من بين لاعبين محليين وعالميين آخرين. تتوفر بيانات حصة السوق للعالم وأمريكا الشمالية وأوروبا وآسيا والمحيط الهادئ (APAC) والشرق الأوسط وأفريقيا (MEA) وأمريكا الجنوبية بشكل منفصل. يفهم محللو DBMR نقاط القوة التنافسية ويوفرون تحليلاً تنافسيًا لكل منافس على حدة.

SKU-66727